OR
CNMD icon

Olympiad Research’s CONMED CNMD Stock Holding History

Olympiad Research’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,972
Closed -$340K – 255
2024
Q4 		$340K Buy
+4,972
New +$346K 0.35% 72
2024
Q3 		– Sell
-3,017
Closed -$209K – 353
2024
Q2 		$209K Sell
3,017
-3,860
-56% -$282K 0.15% 283
2024
Q1 		$551K Buy
6,877
+4,467
+185% +$398K 0.36% 54
2023
Q4 		$264K Buy
2,410
+134
+6% +$13.9K 0.21% 197
2023
Q3 		$230K Buy
+2,276
New +$262K 0.22% 217
2020
Q3 		– Sell
-3,902
Closed -$281K – 367
2020
Q2 		$281K Buy
+3,902
New +$271K 0.2% 130

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Olympiad Research's CNMD Position: Q1 2025 in Review

Olympiad Research sold out of CONMED (CNMD) in Q1 2025, closing a stake of 4,972 shares — an estimated $340K sold.

Olympiad Research first reported a position in CNMD in Q2 2020 and held it in 6 quarters. The position peaked at $551K in Q1 2024. 280 funds tracked by Wall St. Rank hold CNMD as of Q1 2025.

  • Olympiad Research reported no remaining CONMED position as of Q1 2025 after selling out during the quarter.
  • Olympiad Research sold 4,972 CONMED shares in Q1 2025, an estimated $340K.
  • Olympiad Research first reported a position in CONMED in Q2 2020 and held it in 6 quarters.
  • Olympiad Research's CONMED position peaked at $551K in Q1 2024.
  • 280 funds tracked by Wall St. Rank held CONMED as of Q1 2025.

Based on Olympiad Research's 13F filing for Q1 2025, filed 13 May 2025.